Opinion

Video

SPORT Trial

Key Takeaways

  • Pediatric lipid screening is vital for early dyslipidemia detection, reducing future cardiovascular disease risk.
  • Guidelines suggest universal screening at ages 9-11 and 17-21, with selective screening for at-risk children.
SHOW MORE

Panelists discuss how the SPORT trial demonstrated the limited efficacy of dietary supplements compared with traditional lipid-lowering therapies in reducing LDL-C levels.

Related Videos
Confirming Tapinarof’s Efficacy and Safety Across Atopic Dermatitis Severities, with Justin Greiwe, MD
HCPLive Crisis Point Logo | Credit: HCPLive
Investigating Briquilimab’s Efficacy and Safety for CSU, with Thomas Casale, MD
What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025
Ahmad Anouti, MD | Credit: UT Southwestern
Kent Lam I Credit: Macon & Joan Brock Virigina Health Sciences at Old Dominion University
Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD
© 2025 MJH Life Sciences

All rights reserved.